Mark O'Shea

1.1k total citations
7 papers, 975 citations indexed

About

Mark O'Shea is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Mark O'Shea has authored 7 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Mark O'Shea's work include Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (5 papers) and Signaling Pathways in Disease (2 papers). Mark O'Shea is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (5 papers) and Signaling Pathways in Disease (2 papers). Mark O'Shea collaborates with scholars based in United Kingdom, United States and Italy. Mark O'Shea's co-authors include Mark I. Cockett, Andrew Docherty, Gillian Murphy, Gillian Murphy, Richard A. Williamson, Helen Morris, Bryan Ronain Smith, Vera Knäuper, Luciano Zardi and Carlos López-Otı́n and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Mark O'Shea

7 papers receiving 947 citations

Peers

Mark O'Shea

CR

ONCOL

HEMAT

MB

IA

Linda Chung United States

Heli Valtanen Finland

Hiroshi Sato Japan

J.M. Limacher France

H. Tschesche Germany

Laurence Blavier United States

Paula Fukushima United States

Taketoshi Shimada Japan

Leslie Nehring United States

T Hurskainen Finland

Linda Chung United States

Mark O'Shea

509 ×0.6

CR

345 ×0.6

ONCOL

175 ×0.6

HEMAT

246 ×0.8

MB

140 ×0.9

IA

Citations per year, relative to Mark O'Shea Mark O'Shea (= 1×) peers Linda Chung

Countries citing papers authored by Mark O'Shea

Since Specialization

Citations

This map shows the geographic impact of Mark O'Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark O'Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark O'Shea more than expected).

Fields of papers citing papers by Mark O'Shea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark O'Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark O'Shea. The network helps show where Mark O'Shea may publish in the future.

Co-authorship network of co-authors of Mark O'Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Mark O'Shea. A scholar is included among the top collaborators of Mark O'Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark O'Shea. Mark O'Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Knäuper, Vera, Bryan Ronain Smith, Carlos López-Otı́n, et al.. (1997). The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction. Journal of Biological Chemistry. 272(12). 7608–7616. 302 indexed citations

2.

Nguyen, Quang, Frances Willenbrock, Mark I. Cockett, et al.. (1994). Different Domain Interactions Are Involved in the Binding of Tissue Inhibitors of Metalloproteinases to Stromelysin-1 and Gelatinase A. Biochemistry. 33(8). 2089–2095. 66 indexed citations

3.

Willenbrock, Frances, Thomas Crabbe, Patrick M. Slocombe, et al.. (1993). The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A. Biochemistry. 32(16). 4330–4337. 206 indexed citations

4.

Tolley, Shirley P., G.J. Davies, Mark O'Shea, et al.. (1993). Crystallization and preliminary X‐ray analysis of nonglycosylated tissue inhibitor of metalloproteinases‐1, N₃₀QN₇₈Q TIMP‐1. Proteins Structure Function and Bioinformatics. 17(4). 435–437. 7 indexed citations

5.

Murphy, Gillian, Jean‐Pierre Segain, Mark O'Shea, et al.. (1993). The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. Journal of Biological Chemistry. 268(21). 15435–15441. 107 indexed citations

6.

Tolley, Shirley P., Gillian Murphy, Mark O'Shea, et al.. (1993). Crystallization and Preliminary X-ray Analysis of a Truncated Tissue Metalloproteinase Inhibitor Δ128-194 TIMP-2. Journal of Molecular Biology. 229(4). 1163–1164. 6 indexed citations

7.

Murphy, Gillian, et al.. (1991). The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry. 30(33). 8097–8102. 281 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact